- Hippo pathway抑制剂（4）
- 新Hippo pathway产品
Verteporfin treatment inhibits proliferation and induces apoptosis of Tsc1-null cells in vivo. Mice were administered i.p. with vehicle or verteporfin at a dose of 100 mg/kg every other day for 10 d before sacrifice. Mice were sacrificed at 6 wk of age. Three independent experiments were performed and mice in different treatments were pooled for analysis. Percentage of Ki67 and αSMA double-positive cells in α-SMA+ mesenchymal lesions in the indicated kidneys. Immunofluorescence staining and counting were performed on three sagittal sections from different kidney regions for each mouse.
XMU-MP-1是MST1/2的抑制剂，抑制MST1和MST2的IC50分别为71.1±12.9 nM和38.1±6.9 nM。
Peptide 17是YAP-TEAD间蛋白相互作用的抑制剂，在YAP相关的癌症中有其潜在应用价值，IC50为25 nM。